The bid comes two weeks after Street Talk revealed a strategic player was running circles around the ASX-listed vitamin maker, as it rebooted interest from earlier in the year.
Kirin is a large global beer company but has a pharmaceuticals business that it has been growing. Should it be successful with Blackmores, the vitamin maker would be its first sizeable play.Blackmores posted $338 million revenue, 53.3 per cent gross margin, $24.4 million underlying net profit after tax.has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: